BioPharm America EBD Group Massachusetts Biotechnology Council BioPharm America
Share:
Email this page Share this on LinkedIn Share this on Twitter

Panelists and Advisors

Philip Astley-Sparke Philip Astley-Sparke
President US,
uniQure
Peter Barrett Peter Barrett
Partner
Atlas Venture
Kees Been Kees Been
President and CEO
Lysosomal Therapeutics Inc.
Karen  Bernstein Karen Bernstein
Co-Founder, Chairman and Editor-in-Chief
BioCentury
Bruce Booth Bruce Booth
Partner
Atlas Venture
Richard Brudnick Richard Brudnick
VP, Co-Head BD/M&A
Biogen Idec
David Collier David Collier
CEO
Velocity Pharmaceutical Development
Stuart Collinson Stuart Collinson
CEO
Tioga Pharmaceuticals
Bernard Davitian Bernard Davitian
VP and Managing Director,
Sanofi-Genzyme BioVentures
Pamela Demain Pamela Demain
Executive Director
Corporate Licensing
Merck & Co. Inc.
Steve Dickman Steve Dickman
CEO
CBT Advisors
Brian  Gallagher, Jr. Brian Gallagher, Jr.
Partner
SR One
Jim Geraghty Jim Geraghty
Entrepreneur-in-Residence,
Third Rock Ventures
Eric Halioua Eric Halioua
Co-Founder and CEO
Promethera Biosciences
John Hallinan John Hallinan
Chief Business Officer
MassBio
Carl  Jessop Carl Jessop
Due Diligence Director
AstraZeneca
Frederick Jones
Director
Broadview Ventures Inc.
Nilesh Kumar Nilesh Kumar
Director
MS Ventures
Tomas Landh Tomas Landh
Director, Strategy and Innovation Sourcing, Diabetes Research Unit
Novo Nordisk
Philippe Lopes-Fernandes Philippe Lopes-Fernandes
Senior VP and Head,
Global Licensing and Business Development
EMD Serono
Douglas MacDougall Douglas MacDougall
President
MacDougall Biomedical Communications
Ed Mathers Ed Mathers
Partner, Washington DC
NEA
Donnie McGrath Donnie McGrath
Vice President, Search and Evaluation, Business Development
Bristol-Myers Squibb
Robert Millman Robert Millman
Managing Director, MPM
Co-Founder and President
CoStim Pharmaceuticals
Martina Molsbergen Martina Molsbergen
CEO
C14 Consulting Group
Katy Moore Katy Moore
Senior Director, Scientific Licensing Worldwide Business Development
GlaxoSmithKline
Gary Nabel Gary Nabel
CSO
Sanofi
Sridaran Natesan Sridaran Natesan
VP, Stategic Initiatives and Science Relations (North America)
Sanofi
Flemming  Ornskov Flemming Ornskov
CEO
Shire
Doug Plessinger
VP, Clinical and Medical Affairs
Argos Therapeutics
Michal Preminger Michal Preminger
Executive Director
Office of Technology Development
Harvard University
Dennis  Purcell Dennis Purcell
Senior Managing Director
Aisling Capital
Jeffrey L. Quillen Jeffrey L. Quillen
Partner
Foley Hoag LLP
Debanjan Ray Debanjan Ray
VP, Business Development and Alliance Management
CytomX
Brock Reeve Brock Reeve
Executive Director
Harvard Stem Cell Institute
Greg Robinson Greg Robinson
Senior Director
Scientific Licensing Assessment
Shire
Morrie Ruffin Morrie Ruffin
Managing Partner
Adjuvant Partners
Mustafa Sahin Mustafa Sahin
Director, Translational Neuroscience Center
Boston Children's Hospital
Kumar Srinivasan Kumar Srinivasan
VP, Scientific Partnering and Alliances
AstraZeneca
Kevin Starr Kevin Starr
Partner
Third Rock Ventures
Robert Weisskoff Robert Weisskoff
Partner
Fidelity Biosciences
David Yeary David Yeary
VP, Life Sciences
Merrill DataSite
Daphne Zohar Daphne Zohar
Founder, Managing Partner
PureTech Ventures
Arrow Up


© 2009–2014 EBD Group, Inc.
BioPharm America EBD Group Massachusetts Biotechnology Council BioPharm America